Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1997-9-5
|
| pubmed:abstractText |
The "Hepcon/HMS", a small, protable console which can instantaneously measure residual whole blood heparin concentration and automatically compute the necessary dose of additional heparin during extracorporeal circulation and also compute the required dose of protamine to reverse the effect of residual heparin.
|
| pubmed:language |
jpn
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0021-5252
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
50
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
459-62
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:9185440-Cardiopulmonary Bypass,
pubmed-meshheading:9185440-Female,
pubmed-meshheading:9185440-Hemostasis,
pubmed-meshheading:9185440-Heparin,
pubmed-meshheading:9185440-Humans,
pubmed-meshheading:9185440-Male,
pubmed-meshheading:9185440-Monitoring, Intraoperative,
pubmed-meshheading:9185440-Protamines,
pubmed-meshheading:9185440-Whole Blood Coagulation Time
|
| pubmed:year |
1997
|
| pubmed:articleTitle |
[A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
|
| pubmed:affiliation |
Department of Cardiovascular Surgery, Hokko Cardiovascular Hospital, Sapporo, Japan.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Randomized Controlled Trial
|